144 related articles for article (PubMed ID: 31214250)
1. Revisiting Non-BRCA1/2 Familial Whole Exome Sequencing Datasets Implicates
Yin J; Wu K; Ma Q; Dong H; Zhu Y; Hu L; Kong X
Front Genet; 2019; 10():527. PubMed ID: 31214250
[TBL] [Abstract][Full Text] [Related]
2. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
[TBL] [Abstract][Full Text] [Related]
3. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
4. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
Sokolenko AP; Bulanova DR; Iyevleva AG; Aleksakhina SN; Preobrazhenskaya EV; Ivantsov AO; Kuligina ESh; Mitiushkina NV; Suspitsin EN; Yanus GA; Zaitseva OA; Yatsuk OS; Togo AV; Kota P; Dixon JM; Larionov AA; Kuznetsov SG; Imyanitov EN
Int J Cancer; 2014 May; 134(10):2352-8. PubMed ID: 24470238
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing in familial breast cancer patients from Lebanon.
Jalkh N; Chouery E; Haidar Z; Khater C; Atallah D; Ali H; Marafie MJ; Al-Mulla MR; Al-Mulla F; Megarbane A
BMC Med Genomics; 2017 Feb; 10(1):8. PubMed ID: 28202063
[TBL] [Abstract][Full Text] [Related]
7. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
Kim YC; Soliman AS; Cui J; Ramadan M; Hablas A; Abouelhoda M; Hussien N; Ahmed O; Zekri AN; Seifeldin IA; Wang SM
PLoS One; 2017; 12(1):e0167581. PubMed ID: 28076423
[TBL] [Abstract][Full Text] [Related]
8. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Girard E; Eon-Marchais S; Olaso R; Renault AL; Damiola F; Dondon MG; Barjhoux L; Goidin D; Meyer V; Le Gal D; Beauvallet J; Mebirouk N; Lonjou C; Coignard J; Marcou M; Cavaciuti E; Baulard C; Bihoreau MT; Cohen-Haguenauer O; Leroux D; Penet C; Fert-Ferrer S; Colas C; Frebourg T; Eisinger F; Adenis C; Fajac A; Gladieff L; Tinat J; Floquet A; Chiesa J; Giraud S; Mortemousque I; Soubrier F; Audebert-Bellanger S; Limacher JM; Lasset C; Lejeune-Dumoulin S; Dreyfus H; Bignon YJ; Longy M; Pujol P; Venat-Bouvet L; Bonadona V; Berthet P; Luporsi E; Maugard CM; Noguès C; Delnatte C; Fricker JP; Gesta P; Faivre L; Lortholary A; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Servant N; Boland A; Mazoyer S; Deleuze JF; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Int J Cancer; 2019 Apr; 144(8):1962-1974. PubMed ID: 30303537
[TBL] [Abstract][Full Text] [Related]
9. Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.
Suszynska M; Klonowska K; Jasinska AJ; Kozlowski P
Gynecol Oncol; 2019 May; 153(2):452-462. PubMed ID: 30733081
[TBL] [Abstract][Full Text] [Related]
10. Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.
Torrezan GT; de Almeida FGDSR; Figueiredo MCP; Barros BDF; de Paula CAA; Valieris R; de Souza JES; Ramalho RF; da Silva FCC; Ferreira EN; de Nóbrega AF; Felicio PS; Achatz MI; de Souza SJ; Palmero EI; Carraro DM
Front Genet; 2018; 9():161. PubMed ID: 29868112
[TBL] [Abstract][Full Text] [Related]
11. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract][Full Text] [Related]
12. Can unknown predisposition in familial breast cancer be family-specific?
Lynch H; Wen H; Kim YC; Snyder C; Kinarsky Y; Chen PX; Xiao F; Goldgar D; Cowan KH; Wang SM
Breast J; 2013; 19(5):520-8. PubMed ID: 23800003
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
Akter H; Sultana N; Martuza N; Siddiqua A; Dity NJ; Rahaman MA; Samara B; Sayeed A; Basiruzzaman M; Rahman MM; Rashidul Hoq M; Amin MR; Baqui MA; Woodbury-Smith M; Uddin KMF; Islam SS; Awwal R; Berdiev BK; Uddin M
BMC Med Genet; 2019 Sep; 20(1):150. PubMed ID: 31477031
[TBL] [Abstract][Full Text] [Related]
15. A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery.
Chandler MR; Bilgili EP; Merner ND
Hum Mutat; 2016 Sep; 37(9):835-46. PubMed ID: 27226120
[TBL] [Abstract][Full Text] [Related]
16. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
[TBL] [Abstract][Full Text] [Related]
17. Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.
Downs B; Sherman S; Cui J; Kim YC; Snyder C; Christensen M; Luo J; Lynch H; Wang SM
Eur J Cancer; 2019 Jan; 107():68-78. PubMed ID: 30551077
[TBL] [Abstract][Full Text] [Related]
18. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene.
Fostira F; Kostantopoulou I; Apostolou P; Papamentzelopoulou MS; Papadimitriou C; Faliakou E; Christodoulou C; Boukovinas I; Razis E; Tryfonopoulos D; Barbounis V; Vagena A; Vlachos IS; Kalfakakou D; Fountzilas G; Yannoukakos D
J Med Genet; 2020 Jan; 57(1):53-61. PubMed ID: 31300551
[TBL] [Abstract][Full Text] [Related]
19.
Isidori F; Bozzarelli I; Ferrari S; Godino L; Innella G; Turchetti D; Bonora E
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906649
[TBL] [Abstract][Full Text] [Related]
20. Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study.
Li N; Lim BWX; Thompson ER; McInerny S; Zethoven M; Cheasley D; Rowley SM; Wong-Brown MW; Devereux L; Gorringe KL; Sloan EK; Trainer A; Scott RJ; James PA; Campbell IG
NPJ Breast Cancer; 2021 Jun; 7(1):76. PubMed ID: 34117267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
